DOI QR코드

DOI QR Code

Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives Bearing a Heterocyclic Ring at 4/5 Position

  • Wubulikasimu, Reyila (School of Chemistry and Chemical Engineering, Shanghai Jiaotong University) ;
  • Yang, Yanbing (School of Chemistry and Chemical Engineering, Shanghai Jiaotong University) ;
  • Xue, Fei (School of Chemistry and Chemical Engineering, Shanghai Jiaotong University) ;
  • Luo, Xianjin (School of Chemistry and Chemical Engineering, Shanghai Jiaotong University) ;
  • Shao, Dongping (School of Chemistry and Chemical Engineering, Shanghai Jiaotong University) ;
  • Li, Yuhuan (Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College) ;
  • Gao, Rongmei (Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College) ;
  • Ye, Weidong (Zhejiang Medicine Co. Ltd., Xinchang Pharmaceutical Factory)
  • Received : 2013.03.22
  • Accepted : 2013.05.07
  • Published : 2013.08.20

Abstract

A series of novel benzimidazole derivatives bearing a heterocyclic ring as oxadiazole (21-32), thiadiazole (33-34), triazole (35-36) were synthesized and evaluated for their activities against Coxsackie virus B3 and B6 in Vero cells. Compounds 21-26, 31-36 with moieties of 2'-pyridyl, 3'-pyridyl and 4'-pyridyl at the 2-position and oxadiazoles, thiadiazole, or triazole substituent at the 4- or 5-position generally displayed activities against CVB3 and CVB6. Especially compound 24 ($IC_{50}=1.08{\mu}g/mL$, SI = 61.7 against CVB3) was the promising candidate as lead compound for anti-enteroviral drug. It was observed in the incorporation of heterocyclic rings in benzimidazole at the 5-position could enhance their biological activities.

Keywords

References

  1. Barker, H. A.; Smyth, R. D.; Weissbach, H.; Toohey, J. I.; Ladd, J. N.; Volcani, B. E. J. Biol. Chem. 1960, 235, 480.
  2. Kuhler, T. C.; Swanson, M.; Shcherbuchin, V.; Larsson, H.; Mellgard, B.; Sjostrom, J. E. J. Med. Chem. 1998, 41, 1777. https://doi.org/10.1021/jm970165r
  3. Mavrova, A.; Anichina, K. K.; Vuchev, D. I.; Tsenov, J. A.; Denkova, P. S.; Kondeva, M. S.; Micheva, M. K. Eur. J. Med. Chem. 2006, 41, 1412. https://doi.org/10.1016/j.ejmech.2006.07.005
  4. Kohara, Y.; Kubo, K.; Imamiya, E.; Wada, T.; Inada, Y.; Naka, T. J. Med. Chem. 1996, 39, 5228. https://doi.org/10.1021/jm960547h
  5. Mederski, W. W.; Dorsch, D.; Anzali, S.; Gleitz, J.; Cezanne, B.; Tsaklakidis, C. Bioorg. Med. Chem. Lett. 2004, 14, 3763. https://doi.org/10.1016/j.bmcl.2004.04.097
  6. Richards, M. L.; Lio, S. C.; Sinha, A.; Tieu, K. K.; Sircar, J. C. J. Med. Chem. 2004, 47, 6451. https://doi.org/10.1021/jm049288j
  7. Elmer, G. I.; Pieper, J. O.; Goldberg, S. R.; George, F. R. Psychopharmacology (Berl.) 1995, 117, 23. https://doi.org/10.1007/BF02245094
  8. Mader, M.; de Dios, A.; Shih, C.; Anderson, B. D. Bioorg. Med. Chem. Lett. 2008, 18, 179. https://doi.org/10.1016/j.bmcl.2007.10.106
  9. Arjmand, F.; Mohani, B.; Ahmad, S. Eur. J. Med. Chem. 2005, 40, 1103. https://doi.org/10.1016/j.ejmech.2005.05.005
  10. Chien, T. C.; Saluja, S. S.; Drach, J. C.; Townsend, L. B. J. Med. Chem. 2004, 47, 5743. https://doi.org/10.1021/jm040016q
  11. Valdez, J.; Cedillo, R.; Hernandez-Campos, A.; Yepez, L.; Hernandez-Luis, F.; Navarrete-Vazquez, G.; Tapia, A.; Cortes, R.; Hernandez, M.; Castillo, R. Bioorg. Med. Chem. Lett. 2002, 12, 2221. https://doi.org/10.1016/S0960-894X(02)00346-3
  12. Kus, C.; Ayhan-Kilcigil, G.; Ozbey, S.; Kaynak, F. B.; Kaya, M.; Coban, T.; Can-Eke, B. Bioorg. Med. Chem. 2008, 16, 4294. https://doi.org/10.1016/j.bmc.2008.02.077
  13. Hemming, K. In 1,2,4-Oxadiazoles; Alan, R. K., Christopher, A. R., Eric, F. V. S., Richard, J. K. T., Eds.; Comprehensive Hetero cyclic Chemistry III. Elsevier: Oxford, 2008; p 243.
  14. El-Emam, A. A.; Al-Deeb, O. A.; Al-Omar, M.; Lehmann, J. Bioorg. Med. Chem. 2004, 12, 5107. https://doi.org/10.1016/j.bmc.2004.07.033
  15. Kucukguzel, S. G.; Oruc, E. E.; Rollas, S.; Sahin, F.; Ozbek, A. Eur. J. Med. Chem. 2002, 37, 197. https://doi.org/10.1016/S0223-5234(01)01326-5
  16. Kagthara, P. R.; Shah, N. S.; Doshi, R. K.; Parekh, H. H. Indian J. Chem. 1999, 38B, 572.
  17. Akhter, M.; Husain, A.; Azad, B.; Ajmal, M. Eur. J. Med. Chem. 2009, 44, 2372. https://doi.org/10.1016/j.ejmech.2008.09.005
  18. Unangast, P. C.; Shrum, G. P.; Conner, D. T.; Dyer, C. D.; Schrier, D. J. J. Med. Chem. 1992, 35, 3691. https://doi.org/10.1021/jm00098a015
  19. Khan, M. S. Y.; Khan, R. M.; Drabu, S. Indian J. Heterocycl. Chem. 2001, 11, 119.
  20. O'Neal, J. B.; Rosen, H.; Russell, P. B.; Adams, A. C.; Blumenthal, A. J. Med. Chem. 1962, 5, 617. https://doi.org/10.1021/jm01238a019
  21. Luo, Y. P.; Yang, G. F. Bioorg. Med. Chem. 2007, 15, 1716. https://doi.org/10.1016/j.bmc.2006.12.002
  22. Hiroshi, K.; Rokuro, S.; Isao, H.; Takuo, O. J. Agric. Food Chem. 1970, 18, 60. https://doi.org/10.1021/jf60167a005
  23. Prasad, D. J.; Ashok, M.; Karegoudar, P.; Poojary, B.; Holla, B. S.; SuchetaKumari, N. Eur. J. Med. Chem. 2009, 44, 551. https://doi.org/10.1016/j.ejmech.2008.03.025
  24. Walczak, K.; Gondela, A.; Suwinski, J. Eur. J. Med. Chem. 2004, 39, 849. https://doi.org/10.1016/j.ejmech.2004.06.014
  25. Holla, B. S.; Veerendra, B.; Shivananda, M. K.; Poojary, B. Eur. J. Med. Chem. 2003, 38, 759. https://doi.org/10.1016/S0223-5234(03)00128-4
  26. Amir, M.; Shikha, K. Eur. J. Med. Chem. 2004, 39, 535. https://doi.org/10.1016/j.ejmech.2004.02.008
  27. Almasirad, A.; Tabatabai, S. A.; Faizi, M.; Kebriaeezadeh, A.; Mehrabi, N.; Dalvandi, A.; Shafiee, A. Bioorg. Med. Chem. Lett. 2004, 14, 6057. https://doi.org/10.1016/j.bmcl.2004.09.072
  28. Merkle, I.; Van Ooij, M. J. M.; Van Kuppeveld, F. J. M.; Glaudemans, D. H. R. F.; Galama, J. M. D.; Henke, A.; Zell, R.; Melchers, W. J. G. J. Virol. 2002, 76, 9900. https://doi.org/10.1128/JVI.76.19.9900-9909.2002
  29. Xue, F.; Luo, X. Bioorg. Med. Chem. 2011, 19, 2641. https://doi.org/10.1016/j.bmc.2011.03.007
  30. Gilbert, B. E.; Knight, V. Antimicro. Agents Chemother. 1986, 30, 201. https://doi.org/10.1128/AAC.30.2.201
  31. Reed, L. J.; Muench, H. Am. J. Hyg. 1938, 27, 493.

Cited by

  1. Synthesis and Study of α-Glucosidase Inhibitory, Antimicrobial and Antioxidant Activities of Some Benzimidazole Derivatives Containing Triazole, Thiadiazole, Oxadiazole, and Morpholine Rings vol.50, pp.12, 2015, https://doi.org/10.1007/s10593-015-1637-1
  2. Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine vol.349, pp.7, 2016, https://doi.org/10.1002/ardp.201500464
  3. ChemInform Abstract: Synthesis and Biological Evaluation of Novel Benzimidazole Derivatives Bearing a Heterocyclic Ring at 4/5 Position. vol.44, pp.51, 2013, https://doi.org/10.1002/chin.201351156
  4. A Comprehensive Account on Recent Progress in Pharmacological Activities of Benzimidazole Derivatives vol.12, pp.None, 2021, https://doi.org/10.3389/fphar.2021.762807
  5. Synthesis of 4-[(1H-Benzimidazol-2-yl)sulfanyl]benzaldehyde and 2-({4-[(1H-Benzimidazol-2-yl)sulfanyl]phenyl}methylidene)hydrazine-1-carbothioamide vol.2021, pp.3, 2013, https://doi.org/10.3390/m1273